The University of Chicago Header Logo

Connection

Thomas F. Gajewski to Ketoconazole

Back to Details
This is a "connection" page, showing publications Thomas F. Gajewski has written about Ketoconazole.
Thomas F. Gajewski
Connection Strength
0.026
Ketoconazole
  1. Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients. Clin Cancer Res. 2012 Sep 01; 18(17):4785-93.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.